CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Legal & Corp Strategy acquired 39,370 shares (grant or award)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,555 shares (to pay taxes)
- 4 Insider Changes in Ownership
- 4 Grant or award EVP, Commercial acquired 257,731 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Legal Officer gave up 4,398 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 8,761 shares (to pay taxes)
- 4 Insider Changes in Ownership
- 4 Grant or award President and CEO acquired 3,542 shares (grant or award)
- 4 Grant or award Chief Commerical Officer acquired 5,000 shares (grant or award)
- 4 Planned sale Director sold 15,000 shares at $4.46 ($66,843)
- 4 Grant or award Director acquired 59,701 shares (grant or award)
- 4 Grant or award Director acquired 59,701 shares (grant or award)
Page 1 of 65 · 1,293 filings